292 related articles for article (PubMed ID: 36961836)
21. A G Protein-biased Designer G Protein-coupled Receptor Useful for Studying the Physiological Relevance of Gq/11-dependent Signaling Pathways.
Hu J; Stern M; Gimenez LE; Wanka L; Zhu L; Rossi M; Meister J; Inoue A; Beck-Sickinger AG; Gurevich VV; Wess J
J Biol Chem; 2016 Apr; 291(15):7809-20. PubMed ID: 26851281
[TBL] [Abstract][Full Text] [Related]
22. Ezrin, radixin, and moesin phosphorylation in NIH3T3 cells revealed angiotensin II type 1 receptor cell-type-dependent biased signaling.
Ibrahim IA; Nakaya M; Kurose H
J Pharmacol Sci; 2013; 122(1):1-9. PubMed ID: 23575451
[TBL] [Abstract][Full Text] [Related]
23. Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the Gq/11 Protein Pathway and the β-Arrestin Pathway Using Molecular Dynamics Simulations.
Cabana J; Holleran B; Leduc R; Escher E; Guillemette G; Lavigne P
J Biol Chem; 2015 Jun; 290(25):15835-15854. PubMed ID: 25934394
[TBL] [Abstract][Full Text] [Related]
24. Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR).
Xiao K; Sun J; Kim J; Rajagopal S; Zhai B; Villén J; Haas W; Kovacs JJ; Shukla AK; Hara MR; Hernandez M; Lachmann A; Zhao S; Lin Y; Cheng Y; Mizuno K; Ma'ayan A; Gygi SP; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15299-304. PubMed ID: 20686112
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin type 1A receptor regulates β-arrestin binding of the β
Tóth AD; Gyombolai P; Szalai B; Várnai P; Turu G; Hunyady L
Mol Cell Endocrinol; 2017 Feb; 442():113-124. PubMed ID: 27908837
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin (1-7) does not interact directly with MAS1, but can potently antagonize signaling from the AT1 receptor.
Gaidarov I; Adams J; Frazer J; Anthony T; Chen X; Gatlin J; Semple G; Unett DJ
Cell Signal; 2018 Oct; 50():9-24. PubMed ID: 29928987
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin Analogs with Divergent Bias Stabilize Distinct Receptor Conformations.
Wingler LM; Elgeti M; Hilger D; Latorraca NR; Lerch MT; Staus DP; Dror RO; Kobilka BK; Hubbell WL; Lefkowitz RJ
Cell; 2019 Jan; 176(3):468-478.e11. PubMed ID: 30639099
[TBL] [Abstract][Full Text] [Related]
28. Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance.
Violin JD; DeWire SM; Yamashita D; Rominger DH; Nguyen L; Schiller K; Whalen EJ; Gowen M; Lark MW
J Pharmacol Exp Ther; 2010 Dec; 335(3):572-9. PubMed ID: 20801892
[TBL] [Abstract][Full Text] [Related]
29. Mapping Angiotensin II Type 1 Receptor-Biased Signaling Using Proximity Labeling and Proteomics Identifies Diverse Actions of Biased Agonists.
Pfeiffer CT; Wang J; Paulo JA; Jiang X; Gygi SP; Rockman HA
J Proteome Res; 2021 Jun; 20(6):3256-3267. PubMed ID: 33950683
[TBL] [Abstract][Full Text] [Related]
30. Nanobody-Mediated Dualsteric Engagement of the Angiotensin Receptor Broadens Biased Ligand Pharmacology.
Braga Emidio N; Small BM; Keller AR; Cheloha RW; Wingler LM
Mol Pharmacol; 2024 Feb; 105(3):260-271. PubMed ID: 38164609
[TBL] [Abstract][Full Text] [Related]
31. Serodolin, a β-arrestin-biased ligand of 5-HT
El Khamlichi C; Reverchon F; Hervouet-Coste N; Robin E; Chopin N; Deau E; Madouri F; Guimpied C; Colas C; Menuet A; Inoue A; Bojarski AJ; Guillaumet G; Suzenet F; Reiter E; Morisset-Lopez S
Proc Natl Acad Sci U S A; 2022 May; 119(21):e2118847119. PubMed ID: 35594393
[TBL] [Abstract][Full Text] [Related]
32. β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
Mancini AD; Bertrand G; Vivot K; Carpentier É; Tremblay C; Ghislain J; Bouvier M; Poitout V
J Biol Chem; 2015 Aug; 290(34):21131-21140. PubMed ID: 26157145
[TBL] [Abstract][Full Text] [Related]
33. Functional profiling of the G protein-coupled receptor C3aR1 reveals ligand-mediated biased agonism.
Rodriguez P; Laskowski LJ; Pallais JP; Bock HA; Cavalco NG; Anderson EI; Calkins MM; Razzoli M; Sham YY; McCorvy JD; Bartolomucci A
J Biol Chem; 2024 Jan; 300(1):105549. PubMed ID: 38072064
[TBL] [Abstract][Full Text] [Related]
34. Arrestin-dependent angiotensin AT1 receptor signaling regulates Akt and mTor-mediated protein synthesis.
Kendall RT; Lee MH; Pleasant DL; Robinson K; Kuppuswamy D; McDermott PJ; Luttrell LM
J Biol Chem; 2014 Sep; 289(38):26155-26166. PubMed ID: 25081544
[TBL] [Abstract][Full Text] [Related]
35. The nonselective cation channel TRPV4 inhibits angiotensin II receptors.
Zaccor NW; Sumner CJ; Snyder SH
J Biol Chem; 2020 Jul; 295(29):9986-9997. PubMed ID: 32493776
[TBL] [Abstract][Full Text] [Related]
36. Quantifying biased signaling in GPCRs using BRET-based biosensors.
Namkung Y; Radresa O; Armando S; Devost D; Beautrait A; Le Gouill C; Laporte SA
Methods; 2016 Jan; 92():5-10. PubMed ID: 25890247
[TBL] [Abstract][Full Text] [Related]
37. Biased Agonism of the Angiotensin II Type I Receptor.
Ikeda Y; Kumagai H; Motozawa Y; Suzuki J; Komuro I
Int Heart J; 2015; 56(5):485-8. PubMed ID: 26180022
[TBL] [Abstract][Full Text] [Related]
38. Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor.
Kim J; Ahn S; Rajagopal K; Lefkowitz RJ
J Biol Chem; 2009 May; 284(18):11953-62. PubMed ID: 19254952
[TBL] [Abstract][Full Text] [Related]
39. Cellular Assay to Study β-Arrestin Recruitment by the Cannabinoid Receptors 1 and 2.
Bouma J; Soethoudt M; van Gils N; Xia L; van der Stelt M; Heitman LH
Methods Mol Biol; 2023; 2576():189-199. PubMed ID: 36152187
[TBL] [Abstract][Full Text] [Related]
40. Structure-activity relationship study of angiotensin II analogs in terms of β-arrestin-dependent signaling to aldosterone production.
Valero TR; Sturchler E; Jafferjee M; Rengo G; Magafa V; Cordopatis P; McDonald P; Koch WJ; Lymperopoulos A
Pharmacol Res Perspect; 2016 Apr; 4(2):e00226. PubMed ID: 27069636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]